Latest Information Update: 13 Mar 2001
At a glance
- Originator Bioprojet
- Class Antipsychotics
- Mechanism of Action Dopamine D3 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Psychotic disorders
Most Recent Events
- 13 Mar 2001 No-Development-Reported for Psychotic disorders in France (Unknown route)